US Patent Issued to City of Hope on Dec. 16 for "CS1 targeted chimeric antigen receptor-modified T cells" (California Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,440, issued on Dec. 16, was assigned to City of Hope (Duarte, Calif.).

"CS1 targeted chimeric antigen receptor-modified T cells" was invented by Xiuli Wang (Temple City, Calif.) and Stephen J. Forman (Duarte, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Chimeric antigen receptors for use in treating malignant melanoma and other cancers expressing CS1 are described."

The patent was filed on July 10, 2023, under Application No. 18/349,678.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=A...